Actively Recruiting
Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients
Led by The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz · Updated on 2025-12-17
20
Participants Needed
2
Research Sites
83 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Multi-center, randomized, double-blind, placebo-controlled, 12 weeks trial investigating the effects of a nine-strain synbiotic (Vivatlac Synbiotikum) on the gut microbiota of IBS patients
CONDITIONS
Official Title
Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Irritable Bowel Syndrome using the IBS questionnaire for Health Care Providers from the World Gastroenterology Organization
- IBS Severity Scoring System (IBS-SSS) score of 175 points or higher indicating moderate or severe IBS
You will not qualify if you...
- Currently taking or have taken probiotics within the last 3 months
- Currently taking or have taken antibiotics within the last 3 months
- Having a severe illness such as cancer, uncontrolled hypertension or diabetes, liver, kidney or heart problems, serious neurological disorders, psychosis, respiratory diseases like asthma or COPD, or thyroid disorders
- Having chronic bowel disorders other than IBS including inflammatory bowel disease, gastroenteritis, stomach or duodenal cancer, or celiac disease
- Tested positive for Clostridioides difficile
- Pregnant, breastfeeding, or planning pregnancy within the next 3 months
- Diagnosed with lactose intolerance
- Using motility drugs or dietary fiber supplements within 2 weeks before study start
- Taking anti-coagulant medication
- Participated in another clinical trial within the last 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
State Hospital Jarocin
Jarocin, Poland, 63-200
Actively Recruiting
2
State Hospital Jarocin
Jarocin, Poland, 63-200
Actively Recruiting
Research Team
J
Jacek Piatek, Prof. Dr.
CONTACT
H
Henning Sommermeyer, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here